215 related articles for article (PubMed ID: 19571756)
1. How to improve the effectiveness of transurethral resection in nonmuscle invasive bladder cancer?
Cauberg EC; de la Rosette JJ; de Reijke TM
Curr Opin Urol; 2009 Sep; 19(5):504-10. PubMed ID: 19571756
[TBL] [Abstract][Full Text] [Related]
2. Can we improve transurethral resection of the bladder tumour for nonmuscle invasive bladder cancer?
Liem EI; de Reijke TM
Curr Opin Urol; 2017 Mar; 27(2):149-155. PubMed ID: 27941379
[TBL] [Abstract][Full Text] [Related]
3. Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer.
Naselli A; Introini C; Bertolotto F; Spina B; Puppo P
BJU Int; 2010 Jan; 105(2):208-11. PubMed ID: 19549255
[TBL] [Abstract][Full Text] [Related]
4. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors--results of a prospective, randomized comparison to the standard approach.
Geavlete B; Multescu R; Georgescu D; Stanescu F; Jecu M; Geavlete P
Urology; 2012 Apr; 79(4):846-51. PubMed ID: 22342408
[TBL] [Abstract][Full Text] [Related]
5. A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications.
Cauberg EC; de Bruin DM; Faber DJ; van Leeuwen TG; de la Rosette JJ; de Reijke TM
Eur Urol; 2009 Aug; 56(2):287-96. PubMed ID: 19285787
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of nonmuscle invasive transitional cell carcinoma of the bladder: how and how often?
Schmidbauer J; Lindenau G
Curr Opin Urol; 2008 Sep; 18(5):504-7. PubMed ID: 18670275
[TBL] [Abstract][Full Text] [Related]
7. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
Urologiia; 2004; (6):37-40. PubMed ID: 15719729
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors.
Herr HW
Eur Urol; 2015 Apr; 67(4):605-8. PubMed ID: 25041849
[TBL] [Abstract][Full Text] [Related]
9. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.
Richards KA; Smith ND; Steinberg GD
J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761
[TBL] [Abstract][Full Text] [Related]
10. New optical imaging technologies for bladder cancer: considerations and perspectives.
Liu JJ; Droller MJ; Liao JC
J Urol; 2012 Aug; 188(2):361-8. PubMed ID: 22698620
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of conservative therapy with transurethral resection for patients with invasive bladder cancer who cannot tolerate cystectomy.
Akamatsu S; Kanamaru S; Takenawa J; Soeda A
Hinyokika Kiyo; 2007 Dec; 53(12):863-8. PubMed ID: 18203523
[TBL] [Abstract][Full Text] [Related]
12. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.
Herr HW; Donat SM
BJU Int; 2008 Nov; 102(9):1111-4. PubMed ID: 18778359
[TBL] [Abstract][Full Text] [Related]
13. The use of local anesthesia with N-DO injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis.
Brausi MA; Verrini G; De Luca G; Viola M; Simonini GL; Peracchia G; Gavioli M
Eur Urol; 2007 Nov; 52(5):1407-11. PubMed ID: 17507152
[TBL] [Abstract][Full Text] [Related]
14. Perioperative instillation therapy in superficial bladder cancer: is it effective regarding outcome and costs?
Engel RP; Witjes JA
Curr Opin Urol; 2009 Sep; 19(5):511-5. PubMed ID: 19553821
[TBL] [Abstract][Full Text] [Related]
15. Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.
Gudjónsson S; Adell L; Merdasa F; Olsson R; Larsson B; Davidsson T; Richthoff J; Hagberg G; Grabe M; Bendahl PO; Månsson W; Liedberg F
Eur Urol; 2009 Apr; 55(4):773-80. PubMed ID: 19153001
[TBL] [Abstract][Full Text] [Related]
16. Single instillation of mitomycin C reduces 1st year recurrence following transurethral resection of non-muscle invasive bladder cancer.
Ather MH; Aziz S; Sulaiman MN
J Ayub Med Coll Abbottabad; 2007; 19(4):18-20. PubMed ID: 18693589
[TBL] [Abstract][Full Text] [Related]
17. Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate.
Cauberg EC; Mamoulakis C; de la Rosette JJ; de Reijke TM
World J Urol; 2011 Aug; 29(4):503-9. PubMed ID: 21350871
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer.
Goh AC; Tresser NJ; Shen SS; Lerner SP
Urology; 2008 Jul; 72(1):133-7. PubMed ID: 18598789
[TBL] [Abstract][Full Text] [Related]
19. Results of repeated transurethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer: the referral cancer center experience and review of the literature.
Han KS; Joung JY; Cho KS; Seo HK; Chung J; Park WS; Lee KH
J Endourol; 2008 Dec; 22(12):2699-704. PubMed ID: 19025393
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic therapy of superficial bladder cancer in high-risk patients: Holmium laser versus transurethral resection.
Muraro GB; Grifoni R; Spazzafumo L
Surg Technol Int; 2005; 14():222-6. PubMed ID: 16525976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
